Business Wire

Opengear Launches CM8100 Console Manager Enabling Simplified Device Management at Scale for Data Centers

Share

Opengear, a Digi International company (NASDAQ, DGII, www.digi.com/) and leading network resilience solutions provider, announced today that it is launching its new family of console managers, the CM8100. As the latest addition to its award-winning Smart OOBTM Console Server family, the CM8100 delivers a comprehensive solution, adding NetOps capabilities to existing Smart OOBfeatures that simplify connectivity to IT equipment. Moreover, it provides resilient and secure remote access to infrastructure devices while enhancing security and automation for better smart out-of-band management.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220607005005/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

As the latest addition to its award-winning Smart OOB Console Server family, Opengear's CM8100 delivers a comprehensive solution, adding NetOps capabilities to existing Smart OOB features that simplify connectivity to IT equipment. Moreover, it provides resilient and secure remote access to infrastructure devices while enhancing security and automation for better smart out-of-band management. (Photo: Business Wire)

“IT infrastructure needs to be resilient and easy to manage without relying on the network to manage the network,” says Gary Marks, President of Opengear. “Whether IT teams need to bring up new devices, manage existing ones or remediate outages, they must have resilient access to the network from anywhere. Regardless of the state of the production network, Opengear’s CM8100 provides engineers with the remote and reliable connectivity they need to be successful. It is yet another milestone in our long line of solutions designed to help engineers overcome today’s challenges such as travel requirements, security restrictions, and a lack of connectivity.”

CM8100 highlights:

  • Hosts up to 48 managed serial connected devices
  • Hardware-based TPM 2.0 security module providing data encryption and secure boot
  • Open architecture REST API based firmware supporting automation tools, Docker, and Python scripting
  • Four times faster than the previous generation while maintaining power-efficient and passively cooled operation up to 50C
  • Dual AC power supplies with independent monitoring and alerting

The Opengear platform and CM8100 enhance console access with modern automation capabilities. The CM8100 also helps IT personnel remotely provision, manage and remediate devices. Likewise, it enables remote access to even the most sprawling and complex infrastructure, such as switches, routers, PDUs, firewalls, and other critical data center equipment. Additionally, CM8100 appliances establish secure VPN tunnels which connect IT, staff, to remote devices. This provides local access to Ethernet and RS-232 console ports via standard UTP patch cables. The resilient connection of the CM8100 is available to either IT staff or applications to configure managed devices.

“Nearly every enterprise is familiar with the ‘3 a.m.’ call about a down server or a network device but driving or even flying to a data center or remote site can be time-consuming and expensive,” adds Marks. “More than half of IT outages cost over $100,000, so network issues must get fixed quickly. However, if engineers can’t access the network remotely and lack visibility, they will arrive at the site without the right tools or replacement devices to be successful in one trip. With the Opengear platform, IT personnel have the visibility to ascertain the problem from afar and also the access to remediate the outage remotely, saving considerable time and resources.”

For more information about the CM8100, visit https://opengear.com/products/cm8100-console-server/.

To learn more about Opengear, visit: www.opengear.com.

About Opengear

Opengear, a Digi International company, delivers secure, resilient access and automation to support critical IT infrastructure, even when the network is down. Provisioning, orchestration, and remote management of network devices through innovative software and appliances enable technical staff to reliably and efficiently manage data centers and remote network locations. Opengear solutions are trusted by global organizations across financial, digital communications, retail and manufacturing industries. The company is headquartered in New Jersey, with R&D centers in Silicon Valley and Brisbane, Australia. Opengear was acquired by Digi International in 2019, bringing together two organizations with a deep commitment to providing the best products, software and services that meet the demands of mission-critical networks. For more information, please visit www.opengear.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Opengear Contact
Peter Ramsay / Lora Metzner
Global Results Communications
open@globalresultspr.com
949.307.5908

UK/Ireland/Scotland: Opengear Media Relations Contact – Whiteoaks International
Kate Hellig
kateh@whiteoaks.co.uk
+44 (0) 1252 727313 (ext 124)

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Teva Announces Promising Interim Results From Its Study PEARL, About the Impact of AJOVY ® (fremanezumab)24.6.2022 18:54:00 CEST | Press release

Teva Pharmaceuticals Europe B.V. today announces promising interim results from its Pan-European Real World study (PEARL), presented for the first time at the European Academy of Neurology (EAN) Congress in Vienna, Austria. The two-year Pan-European Real World (PEARL) prospective, observational study of AJOVY® (fremanezumab), looks at its effectiveness in patients with chronic migraine or episodic migraine, and is an ongoing study sponsored by Teva Pharmaceuticals Europe BV.1 These findings further offer insight into the treatment of migraine in real-world clinical practice. The interim findings were presented by Faisal Mohammad Amin, Associate Professor of Neurology at the University of Copenhagen, Denmark. Out of the total planned 1100 patients in PEARL, 389 patients are included in the interim analysis presented. These findings show that 54.7% of patients in the study had their monthly-migraine-days reduced by 50% or more, over the six-month period from the start of treatment. Addit

Brigade-M3 European Acquisition Corp. 2021 Annual Report24.6.2022 16:59:00 CEST | Press release

Brigade-M3 European Acquisition Corp. (the “Company”), a special purpose acquisition company that was incorporated on 21 April 2021 under the laws of the Cayman Islands as an exempted company with limited liability and is listed on Euronext Amsterdam, today published its annual report for the period 21 April 2021 to 31 December 2021. The full report can be downloaded from the Company’s website via the following link: https://www.brigadem3eac.com/documents IMPORTANT INFORMATION This press release contains information that qualifies as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation. DISCLAIMER This announcement is not for distribution or release, directly or indirectly, and should not be distributed in or sent into, the United States, Australia, Canada, Japan, the Cayman Islands or South Africa or any other jurisdiction in which such distribution or release would be unlawful or would require registration or other measures. This announcement does n

PUMA Kicks Off Its Largest Web3 Collaboration To Date, with 10KTF Shop24.6.2022 16:41:00 CEST | Press release

PUMA has entered New Tokyo, the virtual city 10KTF calls home. The shop is known for its streetwear offerings and is owned by Wagmi-san, a digital artisan whose collections and NFT community recently welcomed the global sports brand. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220624005314/en/ PUMA Kicks Off Its Largest Web3 Collaboration To Date, with 10KTF Shop PUMA has entered New Tokyo, the virtual city 10KTF calls home. The shop is known for its streetwear offerings and is owned by Wagmi-san, a digital artisan whose collections and NFT community recently welcomed the global sports brand. (Photo: Business Wire) News of the partnership was shared at an event hosted by 10KTF last night in New York. Their event was one of many hosted during the week of NFT.NYC, a conference attended by crypto industry professionals, traders, and other web3 enthusiasts. The official announcement confirms weeks of speculation after PUMA tw

Suzano outlines ESG milestone achievements and commitments at second annual ESG call24.6.2022 16:14:00 CEST | Press release

Suzano, the world’s largest hardwood pulp producer, today held its second annual ESG Call centered around its ambition to be a ‘regenerative company for a regenerative society’. Today’s ESG Call spotlighted measurable progress and ambitions across three core areas of action: climate change, biodiversity and social development. On Climate Change, the ACT initiative of the French Government and CDP scored Suzano ahead of its pulp and paper industry peers in virtually every metric. In 2021, Suzano brought forward its target for removing 40 million tons of carbon dioxide from the atmosphere from 2030 to 2025 which is being achieved through improvements to its industrial processes, such as systematically replacing the use of fossil fuels at its industrial plants with biomass, and through conversion of degraded land. As part of the company’s social commitments, Suzano launched a target in 2020 to lift 200,000 people out of poverty. This is more than pertinent, given that in Brazil, 10% of th

Kyowa Kirin Receives Positive CHMP Opinion for Use of CRYSVITA ® ▼ (burosumab) for the Treatment of Tumour-Induced Osteomalacia (TIO)24.6.2022 15:38:00 CEST | Press release

Kyowa Kirin Co., Ltd. (TSE: 4151, Kyowa Kirin) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended that CRYSVITA® (burosumab) be approved for the treatment of FGF23-related hypophosphataemia in Tumour-Induced Osteomalacia (TIO) associated with phosphaturic mesenchymal tumours (PMTs) that cannot be curatively resected or localised in children and adolescents aged 1 to 17 years and in adults.1 CRYSVITA is also already licensed for use in the rare disease X-Linked Hypophosphataemia (XLH), for children and adolescents between 1 and 17 years of age with radiographic evidence of bone disease, and in adults.2 Also known as oncogenic osteomalacia, TIO is an acquired disorder caused by typically small, slow-growing, benign PMTs.3,4 It is a rare condition with less than 1000 cases reported in the medical literature,4 which mainly affects adults and with a mean onset age of 40 – 45 years.3,5 TIO is associated with p